COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION (CURE)
a Charitable Incorporated Organisation (CIO)
TRUSTEES’ REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30[TH] APRIL 2023
Charity Registration Number 1186032
Page | 1
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
YEAR ENDED 30[TH] APRIL 2023
Contents
| Page | |
|---|---|
| Trustees’ Annual Report | 3 to 5 |
| Statement of Financial Activities | 6 |
| Balance Sheet | 7 |
| Notes to the accounts | 8 to 9 |
Page | 2
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
The trustees present their report and accounts of the charity for the year ended 30[th] April 2023. The financial statements have been prepared in accordance with the accounting policies set out in note 1 and comply with the charity’s constitution, the Charities Act 2011 and ‘Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102)’.
Trustees
Ms Tanya von Ahlefeldt (resigned July 10, 2023) Professor Anthony Mundy (resigned January 11, 2023) Dr Daniela Andrich Mr Isaac Ellis Jacob Mr Richard George Sutton-Mattocks Mr Aslam Hashim Lala Mr Stephen Bennett Moseley (appointed July 10, 2023)
The above named individuals served as trustees from the inception of the charitable incorporated organisation with the exception of Ms Tanya von Ahlefeldt and Mr Stephen Bennett Moseley who were appointed on December 21, 2020 and July 10, 2023 respectively.
Charity Registration Number: 1186032 Charity Office: 50 Havelock Terrace London SW8 4AL Bankers: CAF Bank Ltd 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ
Purpose and activities
The objects of the charity are specifically restricted to such purposes as are exclusively charitable under the laws of England and Wales.
The charitable object of the charity is:-
To promote and protect health for the public benefit by:
a) Providing resources for research into the urological care of patients affected by lower urinary tract conditions and the development of new techniques and lifesaving and life enhancing procedures to achieve and maintain urological health and by disseminating research into such techniques and procedures;
b) Training doctors, nurses and other health practitioners in the latest and most advanced techniques and procedures designed to improve urological health in sufferers.
Page | 3
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
The charitable incorporated organisation came into being on 29[th] October 2019 to take on this work.
Statement on public benefit
The trustees confirm that they have complied with their duty to have due regard to the guidance on public benefit published by the Charity Commission in exercising their powers or duties. The objects and other information set out in this report demonstrate this in more detail.
Charitable Incorporated Organisation (CIO) – structure, governance and management
The charity is governed by its CIO Constitution and was registered with the Charity Commission for England and Wales on 29[th] October 2019.
The first charity trustees were appointed by its constitution. The subsequent trustees are appointed by the charity trustees subject to a minimum number of 3 with no maximum.
Policies and procedures adopted for the induction and training of trustees
The charity recognises that it has a responsibility to provide guidance and assist new trustees in fulfilling their duties and responsibilities, this is done in accordance with Charity Commission guidance. New trustees are given appropriate Charity Commission publications, as well as a copy of the constitution and any amendments to it and the latest copy of its report and accounts.
Achievement and performance
Over the past year, our charity has proudly allocated funds toward acquiring capital equipment essential for a pioneering pre-clinical research endeavour aimed at developing a model for urethral stricture. Esteemed Dr. Daniela Andrich MD MSc FRCS (Urol), serving as Honorary Associate Professor in the Division of Surgery and Interventional Science at UCL and a Consultant Reconstructive Urologist, applied for a grant through the Therapeutic Acceleration Support (TAS) Fund Call 9. This grant would facilitate a ground breaking animal study exploring the potential of MSC (Mesenchymal Stem Cells) in Tissue Regeneration and other critical areas that promise significant advancements in treating urethral strictures. This research, alongside educational initiatives on urethral disorder treatments, embodies the core mission our charity was established to support.
Future plans
The charity is sponsoring registration for a number of junior doctors and nurses at the forthcoming Advanced Urinary Catheterisation Academy (AUCA) hands on advanced urinary catheterisation training. It is also considering how to proceed in raising further funds in furtherance of its objectives.
Finances
The financial transactions involving the charity in the reporting year to 30[th] April 2023 are as per the financial statements on pages 6 to 9.
Reserves
As at 30[th] April 2023 the charity had reserves of £6,274 (2022; £6,155).
Trustees’ responsibilities in relation to the financial statements
The trustees are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and regulations and United Kingdom Accounting Standards,
Page | 4
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
including Financial Reporting Standard102: The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the income and expenditure of the charity for the period. In preparing the financial statements, the trustees are required to:
-
select suitable accounting policies and apply them consistently;
-
observe the methods and principles in charities SORP;
-
make judgements and estimates that are reasonable and prudent;
-
state whether applicable accounting standards have been followed, subject to any departures disclosed and explained in the financial statements; and
-
prepare the financial statements on a going concern basis unless it is inappropriate to presume that the charity will continue in operation.
The trustees are responsible for maintaining proper accounting records which disclose with reasonable accuracy the financial position of the charity and which enable them to ensure that the financial statements comply with the Charities Act 2011, the applicable Charities (Accounts and Reports) Regulations and the provisions of the CIO’s constitution.
They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and irregularities.
Approval
Approved and signed by:
Aslam Lala
26[th ] February 2024 Trustee
Page | 5
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
Statement of Financial Activities for the year ended 30th April 2023
| Note Income Donations Bank interest Total Income Expenditure Total Expenditure Net movement in funds Reconciliation of Funds Total funds brought forward Total funds carried forward |
Total Unrestricted Funds year 2023 £ 6,000 9 6,009 5,890 5,890 119 6,155 6,274 |
Total Unrestricted Funds year 2022 £ 3,005 - |
|---|---|---|
| 3,005 | ||
| 22,824 | ||
| 22,824 | ||
| -19,819 | ||
| 25,974 | ||
| 6,155 |
There were no recognised gains or losses for 2023 or 2022.
Page | 6
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
| Balance Sheet as at 30th April 2023 Note Fixed Assets Current Assets Total Current Assets Creditors: amounts falling due within one year Net current assets Total net assets Funds of the charity: Unrestricted Funds brought forward Net movement in funds Total funds |
2023 £ - - 6,274 - - 6,274 6,274 6,155 119 6,274 |
2022 £ - |
|---|---|---|
| - 6,155 |
||
| - - |
||
| 6,155 | ||
| 6,155 | ||
| 25,974 -19819 |
||
| 6,155 |
Approved and signed by:
Aslam Lala 26[th] February 2024
Trustee
Page | 7
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
Notes to the Financial Statements for the year ended 30[th] April 2023
- 1 Accounting policies
The Charity is a public benefit entity as defined by FRS 102.
The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statement are as follows:
1.1 Basis of preparation of accounts
The accounts are prepared under the historical cost convention and include the results of the charity’s operations which are described in the Trustees’ Annual Report and all of which are continuing.
The accounts have been prepared in accordance with the Statement of Recommended Practice: ‘Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102)’, and with the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), and the Charities Act 2011 and applicable regulations.
1.2 Legal status
The Charity is a Charitable Incorporated Organisation (CIO). The trustees of the CIO are detailed in the Trustees’ Annual Report.
1.3 Recognition of Income
Income is included in the Statement of Financial Activities when:
-
the charity becomes entitled to the resources;
-
it is more likely than not that the charity will receive the resources; and
-
the monetary value can be measured with sufficient reliability.
Income and expenses are not offset, unless permitted by FRS 102 SORP or FRS 102. There was no income for the reporting period.
1.4 Investment gains and losses
This includes any realised gains or losses on the sale of investments and any gain or loss resulting from the revaluation of investments to market value at the balance sheet date.
There were no gains or losses for the reporting period.
- 1.5 Expenditure and liability recognition
Page | 8
COLLABORATION FOR UROLOGICAL RESEARCH AND EDUCATION
TRUSTEES’ REPORT FOR THE YEAR ENDED 30[TH] APRIL 2023
Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably. Expenditure on charitable activities includes the costs incurred in directly undertaking the activities which further the charity’s objectives, as well as any associated support costs. There was no expenditure in the reporting period.
1.6 Going Concern
There are no material uncertainties about the charity’s ability to continue as a going concern.
1.7 Trustee’s remuneration and expenses and related party transactions
Trustees received no emoluments or expense reimbursements in the period. In the previous year 2022, CURE engaged AUCA to deliver 0.5 day hands on advanced urinary catheterisation training to 160 medical professionals including student doctors and nurses in central London. The total cost of this in the current year was £nil (in 2022 it was £20,712 funded by CURE). CURE received a donation of £6,000 from AUCA (2022 £3,000) and £nil from Azbal Ltd (2022 £5) during the year. Dr Daniela Andrich and Mr Aslam Hashim Lala both being Trustees are also Directors of AUCA and Azbal Ltd respectively.
- 2 Post balance sheet events
There are no post balance sheet events to report.
Page | 9